These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24145541)

  • 1. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon.
    Debing Y; Emerson SU; Wang Y; Pan Q; Balzarini J; Dallmeier K; Neyts J
    Antimicrob Agents Chemother; 2014; 58(1):267-73. PubMed ID: 24145541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.
    Todt D; François C; Anggakusuma ; Behrendt P; Engelmann M; Knegendorf L; Vieyres G; Wedemeyer H; Hartmann R; Pietschmann T; Duverlie G; Steinmann E
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2132-9. PubMed ID: 26787701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
    Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
    Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
    Ölschläger S; Neyts J; Günther S
    Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.
    Dao Thi VL; Debing Y; Wu X; Rice CM; Neyts J; Moradpour D; Gouttenoire J
    Gastroenterology; 2016 Jan; 150(1):82-85.e4. PubMed ID: 26408347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
    Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
    Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
    Markland W; McQuaid TJ; Jain J; Kwong AD
    Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
    Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
    Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
    Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
    Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells.
    Chang KO; George DW
    J Virol; 2007 Nov; 81(22):12111-8. PubMed ID: 17855555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
    Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
    J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
    Leyssen P; De Clercq E; Neyts J
    Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rat model for hepatitis E virus.
    Debing Y; Mishra N; Verbeken E; Ramaekers K; Dallmeier K; Neyts J
    Dis Model Mech; 2016 Oct; 9(10):1203-1210. PubMed ID: 27483350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication.
    Praditya DF; Klöhn M; Brüggemann Y; Brown LE; Porco JA; Zhang W; Kinast V; Kirschning A; Vondran FWR; Todt D; Steinmann E
    Antiviral Res; 2022 Aug; 204():105359. PubMed ID: 35728703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
    Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T
    J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replication.
    Debing Y; Winton J; Neyts J; Dallmeier K
    Antiviral Res; 2013 Oct; 100(1):98-101. PubMed ID: 23916729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication.
    Jashés M; Mlynarz G; De Clercq E; Sandino AM
    Antiviral Res; 2000 Jan; 45(1):9-17. PubMed ID: 10774586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?
    Kaushik N; Anang S; Ganti KP; Surjit M
    DNA Cell Biol; 2018 Jul; 37(7):593-599. PubMed ID: 29897788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.